Orthocell Ltd (OCC.AX)
- Closing price (20 Oct 2026, 08:33 PM CET): AUD 0.65
- Price change (24 h): –2.99 %
- Shares outstanding: 280.8 million
- Market capitalisation: AUD 182.5 million
- Volume (last 24 h): AUD 209.1 k of shares traded
- Monthly performance (since last month‑end): –11.56 %
- 200‑day simple moving average: AUD 0.82
- 52‑week high: AUD 1.30 (24 Oct 2025)
- 52‑week low: AUD 0.63 (15 Oct 2026)
Recent Corporate Actions
- No new corporate actions or material announcements were reported for Orthocell during the past 24 hours.
Related Stocks – 24‑Hour Performance
| Company | Ticker | 24‑h change | Current price | Market cap | Notable recent corporate action |
|---|---|---|---|---|---|
| Horizon Gold Limited | HRN.AX | +4.95 % | AUD 1.16 | AUD 216.7 m | Progress on Gum Creek and Gidgee gold projects; new drilling targets identified; ongoing assay work confirming high‑grade gold intercepts. |
| Titomic Limited | TTT.AX | –4.17 % | AUD 0.12 | AUD 214.4 m | Issuance of five million options to Lt. Gen. Henry “Trey” Obering, approved at the most recent AGM; no change to capital structure. |
| Intelligent Monitoring Group Limited | IMB.AX | +0.95 % | AUD 0.52 | AUD 216.9 m | AGM approved remuneration report, director re‑elections, share issuance related to acquisition of ADT Holdings UK Ltd., and employee incentive plan. FY 2026 performance: profitable growth, increased revenue, and expanded operations. |
| Dug Limited | DUG.AX | –2.60 % | AUD 1.48 | AUD 209 m | No new corporate actions disclosed. |
| Vitrafy Life Sciences Ltd | VFY.AX | –5.24 % | AUD 2.75 | AUD 217.9 m | Appointment of Jan Gielen as CFO (effective 1 Feb 2027); former CFO Simon Martin to remain in advisory role for six months. Application to list 5,848 ordinary shares issued under equity incentive plan at nil consideration. |
Company Profile – Orthocell Ltd
Orthocell Ltd operates in the biotechnology sector, focusing on therapeutic solutions for tendon and ligament repair and regeneration within the orthopaedics field. The company is listed on the ASX All Markets and is accessible via its website at www.orthocell.com.au .
